ReviewBiomedicines2025
A Future Picture: A Review of Current Generative Adversarial Neural Networks in Vitreoretinal Pathologies and Their Future Potentials.
Review in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review of Progress of AI in Biomimetics: From Biological Patterns to Closed-Loop Discovery.Biomimetics (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Machine learning has transformed ophthalmology, particularly in predictive and discriminatory models for vitreoretinal pathologies. However, generative modeling, especially generative adversarial networks (GANs), remains underexplored. GANs consist of two neural networks-the generator and discriminator-that work in opposition to synthesize highly realistic images. These synthetic images can enhance diagnostic accuracy, expand the capabilities of imaging technologies, and predict treatment responses. GANs have already been applied to fundus imaging, optical coherence tomography (OCT), and fluorescein autofluorescence (FA). Despite their potential, GANs face challenges in reliability and accuracy. This review explores GAN architecture, their advantages over other deep learning models, and their clinical applications in retinal disease diagnosis and treatment monitoring. Furthermore, we discuss the limitations of current GAN models and propose novel applications combining GANs with OCT, OCT-angiography, fluorescein angiography, fundus imaging, electroretinograms, visual fields, and indocyanine green angiography.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.